Holdings
Knott David M Jr
As of Sep 30, 2026, Knott David M Jr reported 75 positions worth US$173M. Largest: Alphabet Inc (Google) Class C, Apollo Global Management, Inc. (New) and Iovance Biotherapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Alphabet Inc (Google) Class C | 91,720 | US$31.3M | +1,033 | Sep 30, 2026 |
| Apollo Global Management, Inc. (New) | 225K | US$26.1M | no change | Sep 30, 2026 |
| Iovance Biotherapeutics, Inc. | 1.17M | US$17.3M | −435K | Sep 30, 2026 |
| Xeris Biopharma Holdings, Inc. | 1M | US$9.59M | −57,100 | Sep 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 428K | US$8.05M | −8,951 | Sep 30, 2026 |
| Travere Therapeutics, Inc. | 130K | US$7.65M | −17,315 | Sep 30, 2026 |
| BridgeBio Pharma, Inc. | 100K | US$6.58M | +7,150 | Sep 30, 2026 |
| JPMorgan Chase & Co. | 17,409 | US$5.76M | −689 | Sep 30, 2026 |
| Janus Henderson AAA CLO ETF | 93,528 | US$4.72M | new | Sep 30, 2026 |
| Protagonist Therapeutics, Inc. | 32,723 | US$4.61M | −30,277 | Sep 30, 2026 |